SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Memecoin on Cronos launched by the Cro Crow community

crow with knife

$CAW (crow with knife) is trending as the community rallies around its multichain functionality and deflationary tokenomics. Some believe $CAW could bring much-needed volume to the Cronos chain, while others are drawn to the active community and meme-driven appeal. The conversation includes discussion of bridging across chains like SOL, BASE, and BSC.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

WAGMI is trending as its community focuses on building and maintaining a positive outlook, regardless of market conditions. Discussions highlight the community's strong belief in the long-term vision and potential for significant gains, particularly when Solana ($SOL) rebounds. The "We're All Gonna Make It" ethos resonates, driving community engagement and attracting attention.

Welcome to SLAP – The Only Coin That Slaps Harder Than Your Moms  Tired of coins that claim they SLAP but are nothing but limp wrists? SLAP is here to SLAP some sense into the crypto space.  Founded by the Flutter of Five Fingers and powered by the Prancing of the Pried Palm, SLAP isn’t just another coin—it’s an attitude.  We’re not here to talk roadmaps, utility, or world peace. We’re here to SLAP charts, SLAP the haters, and SLAP our way to the top. No VC suits, no corporate nonsense—just raw, unfiltered internet culture with a side of “did we just do that?  ”So load your wallet, mute your financial advisor, and get ready to ride the most unhinged meme rocket. Open up your hands, and start swingin'. You never know what you could hit.  SLAP: It’s not a coin. It’s a lifestyle.

Slap

SLAP is trending as community members rally around the project's ambitious goals and consistent efforts in marketing and development. The community's core question seems to be $WTF IS SLAP, with some speculating its potential for mainstream adoption. Discussions also highlight Team SLAP's MMA fighter Karolina Arm, who promotes the project.

$4CHAN is a meme token on the Ethereum Network.   4ChanToken represents a global crypto community that pays homage to the memetic powerhouses of the internet as Pepe, Doge, Shib and all major memes inventor combining them all into one super meme token that is $4CHAN. At its core, 4ChanToken embodies the untamed spirit of the notorious 4chan imageboard, where iconic memes are born, nurtured, and unleashed upon the world. With an unyielding spirit of irreverence and a touch of mischief, $4CHAN has emerged as the darling of meme enthusiasts, internet dwellers, and crypto aficionados alike.   The foundation of 4ChanToken lies in its community. We’ve harnessed the chaotic energy of this digital realm to create a currency that celebrates the power of memetic expression, empowering users to engage in a truly unique and decentralized economy. As a passionate supporter, you’ll join a vibrant ecosystem where dank memes and viral sensations are the lifeblood of commerce. 4ChanToken is more than just a digital currency – it’s the place where memes are born.  The ultimate playground for memelords and crypto degens. Based on the simplicity of holdrs/volume operating a store of value.  The identification of this value is best described as 'digital gold'. That $4chan can ultimately represent a superior store of value relative to all other forms of memecoins by embodying all memes in one token as the factual birthplace of all popular memes.

4Chan

$4CHAN is trending as community members rally around its potential as the 'Bitcoin of memecoins,' emphasizing its origin story and unique community. Discussions highlight the token's 13 zeros, creating an opportunity for significant gains, and its strong liquidity during market downturns. Some users express excitement about potential runs and whale accumulation, while others debate its long-term viability.

Monad is a high-performance Layer 1 blockchain that processes 10,000 transactions per second with near-zero fees. The platform delivers high performance without compromising on security or decentralization, creating the infrastructure needed for complex applications that require high-frequency activity.  One of Monad’s key innovations lies in how it handles transaction processing. Instead of processing transactions one at a time like traditional blockchains, Monad processes multiple transactions simultaneously through parallel execution.   The system separates the agreement process from the execution process, allowing validators to first agree on which transactions to include and in what order, then having more time to execute those transactions without slowing down consensus. This approach, combined with a custom-built database called MonadDB, dramatically increases throughput while maintaining accuracy.  Monad also offers complete EVM compatibility, where applications built for Ethereum work on Monad without any code modifications, and users can connect with familiar wallets like MetaMask just as they would on Ethereum. Developers can immediately tap into Ethereum's established ecosystem of tools, libraries, and applications while benefitting from Monad’s performance improvements. The platform also runs on consumer-grade hardware rather than expensive specialized equipment, making it accessible for more people to participate in securing the network.  Monad has raised approximately 244 million dollars in total funding across multiple rounds. The company secured 19 million dollars in a seed round in February 2023 led by Dragonfly Capital, followed by a 225 million dollar Series A round in April 2024 led by Paradigm at a 3 billion dollar valuation. Other notable investors include Electric Capital, Greenoaks, Coinbase Ventures, and prominent angel investors such as Naval Ravikant.

Monad

Monad (MON) is trending as the community discusses its potential as a high-speed, EVM-compatible blockchain, with some comparing it to early Ethereum and Solana. The community is focused on its Coinbase listing and potential for staking rewards, while also debating its market cap and long-term viability. Discussions also include speculation around future exchange listings and potential partnerships.

SPDR Gold Trust - SPDR Gold Shares ETF

SPDR Gold Shares ETF

GLD is trending as community members discuss potential catalysts, including speculation around upcoming economic data and central bank policy. Bullish sentiment suggests gold's safe-haven appeal is being recognized amid market uncertainty. Discussions also focus on technical analysis, with some eyeing breakout levels and others highlighting overbought conditions.

The Graph is an indexing protocol and global API for organizing blockchain data and making it easily accessible with GraphQL. Developers can use Graph Explorer to search, find, and publish all the public data they need to build decentralized applications. The Graph Network makes it possible to build serverless dApps that run entirely on public infrastructure.  GRT is the native token of the network that’s used to coordinate work. GRT is an ERC20 token. Node operators, called Indexers, stake and earn GRT for processing queries. Anyone can delegate GRT to Indexers to secure the network and earn rewards. Curators organize data on The Graph by signaling GRT on useful APIs, called subgraphs. Indexers, Delegators, and Curators work together to organize the data for the crypto economy and maintain a useful global API for DeFi and Web3.

The Graph

The Graph (GRT) is trending amid discussions about its potential in the AI and web3 space, with some community members expressing excitement about possible partnerships and technological advancements. However, there's also skepticism related to past performance and token dilution, leading to a debate about its long-term viability and potential for significant price appreciation. Community members are actively discussing entry points, price targets, and whether GRT can break out of its current range.

Based Chad

Based Chad is trending as community members highlight its relative strength compared to other memecoins amid market dips, emphasizing its diamond-handed community and unique buyback mechanisms. Discussions also suggest a potential connection to Coinbase, with executives reportedly holding the token and the meme gaining traction on the platform. The community anticipates further growth, pointing to upcoming video game integrations and staking opportunities.

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Elevance Health Inc

Elevance Health ($ELV) is trending as traders discuss options activity and potential upside, while analysts update ratings. Community members are weighing in on the company's valuation and its position relative to competitors within the managed care sector amid political and economic uncertainty impacting the broader healthcare landscape.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

SMMT is trending as traders discuss the potential for a short squeeze, pointing to high short interest and recent insider buying as key factors. Bullish sentiment is fueled by confidence in the company's pipeline and upcoming data releases, while bears express concerns about the impact of trial results on FDA approval and market competition. Community members are actively debating the company's valuation and potential catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Hits New 52-Week High on Analyst Upgrade

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Reaches New 1-Year High Following Analyst Upgrade...

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Share Price Crosses Above 200 Day Moving Average - Here's Why

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Shares Cross Above 200 Day Moving Average - Time to Sell...

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Trading 8.6% Higher - Here's What Happened

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Shares Up 8.6% - Here's Why...

HC Wainwright Issues Optimistic Estimate for EYPT Earnings

Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT - Free Report) - Equities research analysts at HC Wainwright increased their FY2025 earnings estimates for shares of Eyepoint Pharmaceuticals in a report...

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Announces Earnings Results, Misses Expectations By $0.08 EPS

Eyepoint Pharmaceuticals (NASDAQ:EYPT - Get Free Report) released its earnings results on Wednesday. The company reported ($0.85) earnings per share (EPS) for the quarter, missing analysts' consensus...

Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Given Average Rating of "Moderate Buy" by Analysts

Shares of Eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the seven analysts that are currently covering the firm...

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Given New $39.00 Price Target at Royal Bank Of Canada

Royal Bank Of Canada lifted their target price on Eyepoint Pharmaceuticals from $28.00 to $39.00 and gave the stock an "outperform" rating in a research report on Thursday...

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Down Following Weak Earnings

Eyepoint Pharmaceuticals (NASDAQ:EYPT) Shares Gap Down After Earnings Miss...

EyePoint Pharmaceuticals (EYPT) Reports Q3 Loss, Misses Revenue Estimates

EyePoint Pharmaceuticals (EYPT) delivered earnings and revenue surprises of -10.39% and -85.07%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Nurix Therapeutics (NRIX) Soars 5.6%: Is Further Upside Left in the Stock?

Nurix Therapeutics (NRIX) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

EyePoint Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. It offers FDA-approved sustained-release treatments in ophthalmology under the DEXYCU, ILUVIEN, Verisome, Retisert, and Durasert brands. The company was founded in 1987 and is headquartered in Watertown, MA.

EyePoint Pharmaceuticals Inc

$AMZN

$MSFT

$GOOGL

$ORCL

Which cloud infrastructure stock offers the best long-term opportunity right now?

EYPT
EyePoint Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest EYPT News

EYPTEyePoint Pharmaceuticals Inc